Brain dopamine transporter (DAT) imaging with 123I-FP-CIT SPECT has been used for detecting striatal deficits in clinically uncertain parkinsonism (CUP). Neuromelanin(NM)-MRI assesses nigral depigmentation with high accuracy in confirmed PD; but its diagnostic value in CUP is unclear. Here, we compare nigral NM in CUP with (DAT+) or without (DAT-) striatal dopaminergic deficits, to established PD and healthy controls. CUP with DAT+ had more nigral NM deficits (vs. controls and DAT-CUP) but were less pronounced than in established PD. Interestingly, DAT- cases showed ventrolateral nigral deficits. Our results suggest that nigral depigmentation possibly starts before striatal dopaminergic decline.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords